PH
P. Kent Hawryluk
President & CEO

P. Kent Hawryluk insider trades: MBX Biosciences (MBX) stock buys and sales

President & CEO, MBX Biosciences Last trade May 6, 2026 12 Form 4 filings
$18K
Sold, last 12 months
1 sale
$526K
Bought, last 12 months
1 buy
6
Open-market trades
since 2016
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where P. reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 6, 2026MBX↓ Sell$18K
Mar 13, 2026MBX↑ Buy$526K
Oct 20, 2025MBX↑ Buy$273K
Feb 4, 2025MBX↑ Buy$535K
Mar 10, 2017GEMP↑ Buy$237K
Aug 10, 2016GEMP↑ Buy$250K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MBX insiders

Open-market trades in the last 12 months

About P. Kent Hawryluk's insider trades

P. Kent Hawryluk is President & CEO at MBX Biosciences (MBX). Since Aug 10, 2016, P. has reported 5 open-market purchases worth $1.8M and 1 sale worth $18K on SEC Form 4. In the last 12 months: 1 buy ($526K) and 1 sale ($18K).

Their filings also include grants and awards (5 filings), conversions (2 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.